HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PTCH1
patched 1
Chromosome 9 Β· 9q22.32
NCBI Gene: 5727Ensembl: ENSG00000185920.19HGNC: HGNC:9585UniProt: A0A0C4DGJ5
325PubMed Papers
23Diseases
0Drugs
741Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedReceptorTumor Suppressor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
negative regulation of osteoblast differentiationneural tube patterningapical part of cellperinuclear region of cytoplasmnevoid basal cell carcinoma syndromeholoprosencephalybasal cell carcinomamedulloblastoma
✦AI Summary

PTCH1 (patched 1) functions as a receptor for sonic, indian, and desert hedgehog proteins, associating with smoothened (SMO) to transduce hedgehog signaling 1. The protein acts as a tumor suppressor, with inactivation serving as a critical step in tumorigenesis. PTCH1 mutations are responsible for nevoid basal cell carcinoma syndrome (NBCCS), characterized by multiple basal cell carcinomas and keratocystic odontogenic tumors 2. Germline mutations cause autosomal dominant NBCCS, while somatic mutations occur frequently in sporadic keratocystic odontogenic tumors, with mutations predominantly clustered in extracellular and intracellular loop domains 34. Tumorigenesis involves a two-hit mechanism combining transcriptional silencing and mutational inactivation of PTCH1 alleles 5. Beyond cancer, PTCH1 variants associate with reduced spine bone mineral density and osteoporotic fracture risk 6, and polymorphisms in the gene confer susceptibility to chr9 obstructive pulmonary disease, reflecting PTCH1's role in lung morphogenesis 7. These findings establish PTCH1 as a pleiotropic gene critical for hedgehog signaling, skeletal homeostasis, and pulmonary development.

Sources cited
1
PTCH1 serves as a receptor for hedgehog ligands and negatively regulates hedgehog signaling
PMID: 34562247
2
PTCH1 germline mutations cause basal cell nevus syndrome (NBCCS) and holoprosencephaly
PMID: 29575684
3
PTCH1 mutations are clustered in extracellular loops and large intracellular loop domains in tumors and NBCCS
PMID: 16419085
4
PTCH1 mutations are frequent in both NBCCS-associated and sporadic keratocystic odontogenic tumors
PMID: 24204797
5
PTCH1 tumorigenesis involves transcriptional silencing of one allele followed by mutational inactivation of the other
PMID: 16273213
6
PTCH1 variants associate with reduced spine bone mineral density and osteoporotic fractures
PMID: 26733130
7
PTCH1 polymorphisms are associated with increased chronic obstructive pulmonary disease susceptibility
PMID: 32769486
Disease Associationsβ“˜23
nevoid basal cell carcinoma syndromeOpen Targets
0.80Strong
holoprosencephalyOpen Targets
0.80Strong
basal cell carcinomaOpen Targets
0.77Strong
medulloblastomaOpen Targets
0.62Moderate
hereditary neoplastic syndromeOpen Targets
0.56Moderate
Inherited cancer-predisposing syndromeOpen Targets
0.56Moderate
Abnormality of the skeletal systemOpen Targets
0.55Moderate
genetic disorderOpen Targets
0.51Moderate
major depressive disorderOpen Targets
0.47Moderate
intelligenceOpen Targets
0.47Moderate
osteoarthritis, hipOpen Targets
0.45Moderate
osteoarthritis, kneeOpen Targets
0.44Moderate
pilocytic astrocytomaOpen Targets
0.42Moderate
smoking initiationOpen Targets
0.41Moderate
neurotic disorderOpen Targets
0.40Moderate
microform holoprosencephalyOpen Targets
0.40Weak
type 2 diabetes mellitusOpen Targets
0.40Weak
skin basal cell carcinomaOpen Targets
0.40Weak
atrial fibrillationOpen Targets
0.39Weak
colorectal adenocarcinomaOpen Targets
0.38Weak
Basal cell carcinomaUniProt
Basal cell nevus syndrome 1UniProt
Holoprosencephaly 7UniProt
Pathogenic Variants741
NM_000264.5(PTCH1):c.290dup (p.Asn97fs)Pathogenic
Gorlin syndrome|not provided|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 97
NM_000264.5(PTCH1):c.1863_1864del (p.Arg621fs)Pathogenic
Gorlin syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 621
NM_000264.5(PTCH1):c.2833C>T (p.Arg945Ter)Pathogenic
not provided|Hereditary cancer-predisposing syndrome|Gorlin syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 945
NM_000264.5(PTCH1):c.1213G>T (p.Glu405Ter)Pathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 405
NM_000264.5(PTCH1):c.567_580del (p.His189fs)Pathogenic
Hereditary cancer-predisposing syndrome|Gorlin syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 189
NM_000264.5(PTCH1):c.584+1G>APathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025
NM_000264.5(PTCH1):c.1348-2A>GPathogenic
not provided|Gorlin syndrome
β˜…β˜…β˜†β˜†2025
NM_000264.5(PTCH1):c.1501C>T (p.Gln501Ter)Pathogenic
Gorlin syndrome|Basal cell nevus syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 501
NM_000264.5(PTCH1):c.2541C>G (p.Tyr847Ter)Pathogenic
not provided|Gorlin syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 847
NM_000264.5(PTCH1):c.394+1G>APathogenic
Hereditary cancer-predisposing syndrome|not provided|Gorlin syndrome
β˜…β˜…β˜†β˜†2025
NM_000264.5(PTCH1):c.379G>T (p.Glu127Ter)Pathogenic
Gorlin syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 127
NM_000264.5(PTCH1):c.2569del (p.Asp857fs)Pathogenic
Gorlin syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 857
NM_000264.5(PTCH1):c.3488G>T (p.Gly1163Val)Likely pathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 1163
NM_000264.5(PTCH1):c.233G>A (p.Trp78Ter)Pathogenic
Gorlin syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 78
NM_000264.5(PTCH1):c.2042C>T (p.Pro681Leu)Pathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 681
NM_000264.5(PTCH1):c.387G>A (p.Trp129Ter)Pathogenic
Gorlin syndrome|Basal cell nevus syndrome 1|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 129
NM_000264.5(PTCH1):c.2713C>T (p.Gln905Ter)Pathogenic
Gorlin syndrome|not provided|Basal cell nevus syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 905
NM_000264.5(PTCH1):c.454_455del (p.Met152fs)Pathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 152
NM_000264.5(PTCH1):c.2197_2198del (p.Ser733fs)Pathogenic
Gorlin syndrome|Hereditary cancer-predisposing syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 733
NM_000264.5(PTCH1):c.2250+1G>TPathogenic
Gorlin syndrome|not provided
β˜…β˜…β˜†β˜†2025
View on ClinVar β†—
Related Genes
GRK2Protein interaction100%BBS1Protein interaction100%GAS1Protein interaction100%GPC3Protein interaction100%KIF7Protein interaction100%LRP2Protein interaction99%
Tissue Expression6 tissues
Brain
100%
Ovary
94%
Heart
72%
Lung
62%
Liver
42%
Bone Marrow
34%
Gene Interaction Network
Click a node to explore
PTCH1GRK2BBS1GAS1GPC3KIF7LRP2
PROTEIN STRUCTURE
Preparing viewer…
PDB6RTW Β· 1.90 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.15Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.09 [0.06–0.15]
RankingsWhere PTCH1 stands among ~20K protein-coding genes
  • #1,013of 20,598
    Most Researched325 Β· top 5%
  • #62of 5,498
    Most Pathogenic Variants741 Β· top 5%
  • #197of 17,882
    Most Constrained (LOEUF)0.15 Β· top 5%
Genes detectedPTCH1
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Sequence variants in the PTCH1 gene associate with spine bone mineral density and osteoporotic fractures.
PMID: 26733130
Nat Commun Β· 2016
1.00
2
Expression, Purification, and Structure Determination of Human PTCH1-HH-N Complexes.
PMID: 34562247
Methods Mol Biol Β· 2022
0.90
3
Novel PTCH1 Mutation Causes Gorlin-Goltz Syndrome.
PMID: 38546523
Chin J Dent Res Β· 2024
0.84
4
PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.
PMID: 24204797
PLoS One Β· 2013
0.80
5
A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing.
PMID: 16273213
Int J Oncol Β· 2005
0.70